R03 – Modification of a Parenting Intervention for Primary Care Based Delivery to Women with Perinatal Depression and Anxiety: Promoting First Relationships

Principal Investigators
Amritha Bhat, MD, MPH, Acting Assistant Professor, Psychiatry and Behavioral Sciences
Monica Oxford, PhD, Professor, Nursing
Project Description
Women with PDA frequently experience parenting challenges which are associated with both worsening postpartum depression and negative child outcomes. These parenting factors do not respond to PDA treatments alone, and persist after remission of maternal depressive symptoms, underscoring the importance of including attention to parenting in maternal PDA treatments. By using mental health and parenting support expertise and user centered design, this study will improve usability of a parenting intervention for delivery in conjunction with Collaborative Care for PDA in primary care, with the goal of enhancing access to PFR for women with PDA.
Setting | Primary care |
Population | Women with Perinatal Depression and Anxiety (PDA) |
Intervention and/or Implementation Strategy Designed or Redesigned
Intervention | Development of PFR-Brief (PFR-B) protocol through collaboration with Care Managers and PFR therapists to modify PFR features for primary care delivery. The intervention will be tested in microtrials within the primary care CC framework. |
Implementation Strategy | Iterative development using Participatory Design Group including CC team members (Primary Care Provider, Psychiatric Consultant and Care Manager) with feedback from 6 women receiving PFR-B. Individual interviews with patients and CMs after PFR-B sessions will alternate with PDG focus groups to refine the protocol. |
Impact
This study will lead to the development of a PFR-B protocol for testing in a future larger clinical trial, ultimately enhancing access to Promoting First Relationships interventions for women with PDA. The modified intervention addresses critical parenting challenges that persist even after maternal depressive symptoms improve, potentially improving both maternal outcomes and child development outcomes in this vulnerable population.